FDA OKs new therapy for some hemophilia patients

FDA OKs new therapy for some hemophilia patients



U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.